SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-277540
Filing Date
2022-11-04
Accepted
2022-11-04 09:45:32
Documents
14
Period of Report
2022-11-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d373091d8k.htm   iXBRL 8-K 32229
2 EX-99.1 d373091dex991.htm EX-99.1 13955
6 GRAPHIC g373091newpage1.jpg GRAPHIC 12004
  Complete submission text file 0001193125-22-277540.txt   186196

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acor-20221104.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20221104_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20221104_pre.xml EX-101.PRE 11260
8 EXTRACTED XBRL INSTANCE DOCUMENT d373091d8k_htm.xml XML 3402
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 221360631
SIC: 2836 Biological Products, (No Diagnostic Substances)